+Vote!
PR News Wire (Free subscription) | yesterday
Dr. Horvath will drive the transition of basic research emerging from Dr. Holers' laboratory into the development phase. He will oversee pharmacology, PK/PD, toxicology, pathology and biological assays. He brings to Taligen extensive experience in the preclinical development and regulatory work required to file Investigational New Drug (IND) applications. Dr. Horvath has been responsible for non-clinical...
+Vote!
Market Wire (Free subscription) | 8 hours ago
SAN FRANCISCO, CA (MARKET WIRE) Outspark, a leading entertainment services company that publishes and operates engaging online multiplayer games, is excited to announce the arrival of Paul Thind as the company's chief business officer. A seasoned executive with more than 15 years of experience, Mr. Thind will oversee Outspark's growing game publishing business, its portal...
+Vote!
PR News Wire (Free subscription) | 10 hours ago
Regado Biosciences is pioneering a new therapeutic field with the creation and development of two-component drug systems, comprising an aptamer therapeutic that can be controlled directly by its specific and matched reversal agent. Regado's technology is designed to give physicians the ability to directly control and titrate each system's therapeutic effect. Enhanced control and flexibility allow physicians...
+Vote!
Indian Express (Free subscription) | 21 hours ago
... commodities a few days ago with similar contracts of all the four commodities,” Unupom Kausik, chief business officer, NCDEX, said. Similarly, the Multi-Commodity Exchange (MCX) has also sought permission from the FMC to re-launch futures trade in four commodities with same contract specifications for barring potato. “We have asked for a change in specifications for potato...
